Global Foot and Ankle Allografts Market report, By Product Type(Allograft Wedges, Allograft Tendons, Allograft Acellular Dermal Matrix, Cartilage Allograft Matrix, Skin Allografts, Amniotic Membranes), By Surgery type( arthrodesis Procedures, Osteotomy Procedures, Others), End user (Hospitals, Orthopedic Clinics, Ambulatory Center), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast is projected to reach USD 5.1 billion by 2025, at a CAGR of 5.6% during the forecast period of 2018 to 2025. Hospital segment is expected to dominate the market with a share of 56.3% and is expected to reach USD 228.98 million by 2025 from USD 153.21 million in 2016 growing at the highest CAGR of 5.6% in the forecast period 2018 to 2025.
Access Full Report: https://databridgemarketresearch.com/reports/global-foot-ankle-allograft-market/
Allografts are mostly used during reconstructive procedures around the foot and ankle. As compared with autograft tissue, allografts offer advantages of unlimited tissue sources, decrease in the operative time, and lack of potential donor-site morbidity. Allografts can be classified in to three broad categories (1) Osteochondral grafts, (2) Osseous/structural grafts, and (3) Allograft tendons .The use of these grafts has increased dramatically in the past decade. The lack of formal education and training may hinder the growth of this market in the U.S. Allografts are used in various procedures that involve joint reconstruction, ACL repair, reconstruction due to cancer or trauma, urological procedures and spinal fusion.
Bone graft is a common procedure followed in the orthopedic surgery that helps in fusions, fracture repair, and reconstruction of skeletal defects. Auto graft involves transporting a bone from a donor site to another location in the same patient. It shows no risk of disease transmission.
The quantity of allograft bone is essentially unlimited and is, therefore, valuable for use in treating very large defects that exceed the yield of the iliac crest. Allografts are particularly helpful in the case of obese patients or patients with systemic disease as they have the potential of reduced blood loss and anesthesia time.
One of the major applications of dehydrated amniotic-derived tissue allograft is its use in Diabetic Foot Ulcers. DAMA (dehydrated amniotic-derived tissue allograft) was applied by trimming it to fit on the wound (~1mm overlap of wound margins) under disinfected conditions. DAMA was permitted to self-adhere and was then covered using non-adherent contact layer, protected with retention tape and then covered with foam dressing. The number of DAMA applications and time between DAMA applications was based on the physician’s judgment of need for additional applications.
The global market for Foot and Ankle Allograft by the following sub-categories is presented
Some of the major factors driving the market for global foot and ankle allograft market are:
Increasing numbers of sports injuries:
In the U.S., about 30 million children and teens participate in some form of organized sports, and more than 3.5 million injuries occur each year.
Few sports are more dangerous than others, such as contact sports including football can be expected to result in a higher number of injuries than a non-contact sport such as swimming.
Below are few statistics mentioned in National SAFE KIDS Campaign and the American Academy of Pediatrics:
More than 775,000 children, aged 14 and younger, are treated in the hospital emergency rooms for sports-related injuries each year. Sporting injuries around the ankle vary from simple sprains that will resolve spontaneously within a few days to severe injuries which may never fully recover and may threaten the career of a professional athlete. Some of these injuries can be easily overlooked altogether or misdiagnosed with potentially devastating effects on future performance
Rising number of aging and geriatric population:
According to the Global Health and Aging report presented by the World Health Organization (WHO), the number of people aged 65 or older are projected to grow from an estimated 524 million in 2010 to about 1.5 billion in 2050, with most of the increase in developing countries. There are certain health conditions that are expected to be a challenge to our health care system with the increasing aging population. These conditions include cancer, dementia, increase in the number of falls, obesity, and diabetes.
The world’s older population continues to grow at an unprecedented rate. Today, 8.5% of people worldwide (617 million) are aged 65 and over.
At present, 8% of the world population is over 65 years of age, and this percentage is expected to increase to 20% in 20 years, with many of these people being older than 80. For example, it is estimated that in Italy there will be more than one million people over 90 in the year 2024 and, in China, it is estimated that 330 million people will be older than 65 and 100 million will be older than 80 in 2050. The growth of the elderly population is considered a` global phenomenon.
These factors increase the demand for products such as allograft wedges, allograft tendons, allograft acellular dermal matrix, cartilage allograft matrix, skin allografts and amniotic membrane. Allografts are used in various procedures like joint reconstruction in the knee and ankle, ACL repair, reconstruction due to cancer or trauma, urological procedures, spinal fusion, shoulder repair.
Some of the major market players in Foot and Allograft Market are, CONMED Corporation, Wright Medical Group N.V., AlloSource, Amniox Medical, Inc., Bone Bank Allografts, RTI Surgical, Inc., Zimmer Biomet, Arthrex, Inc.,JRF Ortho,Musculoskeletal Transplant Foundation ,Integra Life Sciences Corporation, Lattice Biologics Ltd., Smith & Nephew plc, Tornier N.V. (Netherlands), Össur (Iceland), Acumed, LLC (U.S.), and Extremity Medical, LLC (U.S.).
Global foot and ankle allograft market is dominated by CONMED Corporation, followed by Wright Medical Group N.V. and RTI Surgical, Inc. The foot and ankle allograft market in the global region is leading in North America, Europe, Asia-Pacific, South America and Middle East and Africa. North America accounts for the highest market share in this region. Allograft acellular dermal matrix segment is expected to dominate the global foot and ankle allograft market.
Browse Related Reports:
North America Orthobiologics Market, By Type, By End-User, By Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024.
Global Orthobiologics Market By Product Type, End User, Geography (North America, Europe, APAC, South America, MEA)–Industry Trends and Forecast to 2024.
Global Trauma Fixation Devices Market by Types (Internal Fixator Devices (Plates, Screws, Rod Wires & Pins, Fusion Nails), External Fixator Devices), By End-User (Hospital, Orthopedic Clinic) By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa) – Industry Trends and Forecast to 2024.
Asia-Pacific Foot and Ankle Allograft Market – Industry Trends and Forecast to 2027
Europe Foot and Ankle Allograft Market – Industry Trends and Forecast to 2027
North America Foot and Ankle Allograft Market - Industry Trends and Forecast to 2027
Global Foot and Ankle Allograft Market – Industry Trends and Forecast to 2026